Sponsor or institution
Clinical trials and research at First Affiliated Hospital of Fujian Medical University
As of November 12, 2026, Find a Trial lists 45 clinical trials run by First Affiliated Hospital of Fujian Medical University that are recruiting, in China. 1 was first registered in the last 30 days. By phase: Early Phase 1 (7), Phase 1/2 (3), Phase 2/3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 45Clinical trials
- 1New in 30 days
- 1Country
Newest trials
All recruiting trials (45)
-
Delayed Ga-68 DOTATATE PET/MR for Detecting Liver Metastases in GEP-NETs
This study tests whether a delayed Ga-68 DOTATATE PET/MR scan can better detect liver metastases in gastroenteropancreatic neuroendocrine tumors compared with the standard Ga-68 DOTATATE PET/CT.
-
Preventive Narrative Exposure for PTSD After Cardiac Surgery in the ICU
In adults having cardiopulmonary bypass heart surgery, this trial tests whether an ICU-based narrative exposure intervention helps prevent posttraumatic stress symptoms compared with standard care.
-
A lifetime registry and imaging database for people with heart, kidney, and metabolic conditions
This project will see if creating a long-term clinical and imaging database for adults with heart, kidney, or metabolic conditions can improve prediction of outcomes and guide care.
-
Low-intensity focused ultrasound targeting the globus pallidus to improve movement in Huntington's disease
This trial tests whether different pulse frequencies of low-intensity focused ultrasound (LIFU) aimed at a deep brain target can safely reduce chorea and other motor symptoms in adults with Huntington's disease.
-
Using AI language models to help diagnose and recommend treatments for urologic conditions
This project will test whether three AI language models (ChatGPT, Gemini, DeepSeek) can accurately recognize urologic diseases and suggest diagnoses and treatments from archived hospital records of adult patients.
-
Sequential 225Ac-LNC1011 treatment for metastatic castration-resistant prostate cancer
We'll test whether different doses of a PSMA-targeted alpha therapy called 225Ac-LNC1011 are safe and can shrink tumors in men whose prostate cancer has spread and no longer responds to hormone therapy.
-
GRPR PET imaging for diagnosis and staging of prostate cancer
This will test two new GRPR PET tracers (68Ga-G21 and 68Ga-G23) alongside 68Ga-PSMA-11 to see if they better detect and stage prostate cancer in men with confirmed disease.
-
Different doses of corticosteroid in local knee injection for total knee replacement
This will test whether adding different doses of Diprospan to the local pain injection given during primary unilateral total knee replacement reduces postoperative pain and improves early recovery.
-
Adding rifampin to antibiotics after DAIR for staphylococcal periprosthetic joint infection
This trial tests whether giving rifampicin in addition to standard antibiotics for adults with staphylococcal periprosthetic joint infection after DAIR improves long-term infection control.
-
Taining Golden Lake comprehensive chronic disease management program
This project will build a large cohort of adults in Taining County to collect health data and try to create a county-level chronic disease management model for people with hypertension, diabetes, dyslipidemia, and other long-term conditions.
-
Bacteroides fragilis plus branched-chain amino acids to help clear HBsAg
This project tests whether adding Bacteroides fragilis and branched-chain amino acids to routine antiviral therapy helps people with chronic hepatitis B clear HBsAg.
-
68Ga-PSMA-11 PET versus mpMRI for diagnosing prostate cancer
This test will see if 68Ga-PSMA-11 PET scans (PET/CT or PET/MRI) find prostate cancer more accurately than multiparametric MRI in men with newly diagnosed, untreated prostate cancer.
-
Early methylprednisolone for large infarct strokes with low lymphocyte counts
This study will test whether giving methylprednisolone early, along with clot-removal treatment, helps adults with large anterior strokes and low blood lymphocyte counts live longer and recover better by 90 days.
-
Multimodal PET Imaging to Help Plan Epilepsy Surgery
This study tests three PET scans (18F-FDG, SV2A, and TSPO) in people with drug-resistant focal epilepsy to help plan resection or SEEG and see if the scans improve localization of seizure-causing brain areas.
-
PH-DyPred: Multimodal dynamic risk prediction in pulmonary hypertension
This project will try to build a prediction model using scans, ECGs, blood tests, and clinical data to see which adults with pulmonary hypertension are at higher risk of hospitalization, worsening symptoms, or death.
-
68Ga-PSMA-CYC PET imaging for diagnosing, staging, and restaging prostate cancer
This trial will test a new PET tracer called 68Ga-PSMA-CYC to see if it safely finds and stages prostate cancer in men and how it compares with current PSMA tracers.
-
Improved robotic surgery for advanced prostate cancer
This study tests a new robotic surgery technique for advanced prostate cancer to see if it helps improve recovery and urinary control compared to standard methods.
-
PSMA PET/MRI-guided prostate biopsy for men with prior negative biopsies and low PI-RADS
This trial will try whether PSMA PET/MRI-guided targeted biopsies find more clinically significant prostate cancer than standard TRUS transperineal saturation biopsies in men with prior negative biopsies, rising PSA or PHI, and PI-RADS ≤3.
-
Neoadjuvant treatment for gastric cancer using Envafolimab and Fruquintinib with chemotherapy
This study is testing if a new combination of Envafolimab, Fruquintinib, and chemotherapy can help people with locally advanced gastric cancer do better before surgery.
-
Imaging with a new PET tracer in cancer patients
This study is testing a new imaging tool for cancer patients to see if it can find tumors better than current methods.
-
Evaluating a new imaging agent for cancer detection
This study is testing a new imaging agent for cancer called 18F-FAPI-Biotin to see if it can help doctors find tumors better than current imaging methods.
-
First use of 68Ga-NI-FAPI PET/CT for cancer diagnosis
This study is testing a new imaging agent called 68Ga-NI-FAPI to see if it can help doctors better spot different types of cancer using PET/CT scans.
-
Study of a new radiotracer for cancer imaging
This study is testing a new imaging agent for cancer to see how well it helps doctors spot tumors in patients with different types of cancer.
-
Observational study of patients with spontaneous intracerebral hemorrhage
This study is looking at patients with spontaneous brain bleeding to see how they recover and what long-term effects they might have.
-
Evaluating a new radiotracer for cancer imaging
This study is testing a new imaging agent for cancer that helps doctors see tumors better by focusing on a specific protein found in cancer cells.
-
Using advanced imaging to diagnose and predict treatment outcomes for bladder cancer
This study is testing new imaging techniques to see if they can better diagnose muscle-invasive bladder cancer and predict how well patients will respond to chemotherapy.
-
Evaluation of KHA80 hemoperfusion in hemodialysis patients
This study is testing if adding KHA80 hemoperfusion to regular hemodialysis can lower certain harmful substances in the blood for patients who are on hemodialysis.
-
Combining adebrelimab with apatinib, gemcitabine, and cisplatin for treating biliary tract cancers
This study is testing a new combination of medications to see if it can help people with high-risk biliary tract cancers do better before surgery.
-
Combination therapy for HER2-positive breast cancer
This study is testing a new combination of treatments for women with HER2-positive breast cancer to see if it helps them respond better to therapy before surgery.
-
Evaluating antibiotic treatment after joint revision surgery for infection
This study is testing if a specific antibiotic treatment after joint revision surgery for infection can help patients recover better and prevent further infections.
-
Using 68Ga-Pentixafor PET/CT to improve diagnosis and treatment of primary aldosteronism
This study is testing a new imaging method to see if it can help doctors better diagnose and treat people with primary aldosteronism, a condition that causes high blood pressure.
-
Minimally invasive treatment for deep brain bleeding
This study is testing a new, less invasive treatment for deep brain bleeding to see if it helps patients recover better than standard care when given soon after symptoms start.
-
See if CXCR4 PET imaging helps diagnose and predict outcomes for lymphoproliferative diseases
This early-phase imaging study tests whether 68Ga-Pentixafor PET/CT can help diagnose and predict prognosis for people with suspected or untreated lymphoproliferative diseases.
-
68Ga-FAPI PET/CT imaging to detect primary and metastatic cancer lesions
This study tests whether 68Ga-DOTA/NOTA-FAPI-04 PET/CT can help find primary tumors and metastases in adults with various cancers.
-
Observational cohort study on Facioscapulohumeral Muscular Dystrophy Type 1
This study is collecting information from people with Facioscapulohumeral Muscular Dystrophy Type 1 in China to better understand how the condition affects them and help doctors make better treatment decisions.
-
Registry for Cerebral Small Vessel Disease
This study is looking at how Cerebral Small Vessel Disease affects people over time and what factors might help doctors manage it better.
-
Registry for CADASIL patients and their relatives
This study is trying to learn more about CADASIL and how it affects patients and their families to improve care and understanding of the condition.
-
Observational study on Duchenne Muscular Dystrophy
This study looks at how Duchenne Muscular Dystrophy and similar conditions develop over time in patients to help improve their care.
-
Observational study on Wilson's Disease
This study looks at how Wilson's Disease affects people in different ways to help improve care for patients and their families.
-
Cohort study on spinal muscular atrophy in China
This study is trying to learn more about spinal muscular atrophy by looking at how it affects different patients in China and how their genes relate to their symptoms.
-
Cohort study on cerebellar ataxia in South-East China
This study is gathering information from patients with cerebellar ataxia in South-East China and their families to better understand the condition and its causes.
-
Observational study on brain calcification characteristics
This study is trying to learn more about brain calcification by looking at patients with calcium deposits in their brains, their family members, and healthy individuals to see how it affects health over time.
-
Analyzing the natural history of Charcot-Marie-Tooth disease
This study is trying to learn more about Charcot-Marie-Tooth disease by looking at the experiences of patients in China to improve how it's treated.
-
Observing the natural history of amyotrophic lateral sclerosis in patients
This study is looking at how amyotrophic lateral sclerosis (ALS) progresses in Chinese patients to better understand the disease and find out what might affect its course.
-
Observational study on spastic paraplegia
This study is trying to learn more about how hereditary spastic paraplegia affects people over time so that doctors can better manage the condition.
Quick answers
How many clinical trials run by First Affiliated Hospital of Fujian Medical University are recruiting right now?
45, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 7, Phase 1/2: 3, Phase 2/3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.